Breast Screening Guideline Debates
Key Questions
What are the ACP's new breast screening guidelines for average-risk women?
The ACP recommends biennial mammography for asymptomatic, average-risk women aged 50-74. For those with BI-RADS category C or D breast density, clinicians may consider supplemental digital breast tomosynthesis (DBT). The ACP rejects routine use of MRI, ultrasound, or contrast-enhanced mammography.
Why have the ACP guidelines been criticized?
Organizations like ACR, SBI, and Spear criticize the ACP guidelines as potentially deadly due to biennial screening starting at 50, arguing it misses cancers in younger women and dense breasts. They advocate for annual screening from age 40 for average-risk and earlier for high-risk.
What do ACS and NCCN recommend for breast cancer screening?
ACS recommends annual screening from age 40 for average-risk, with risk assessment at 25/35 and AI mammography from 35; high-risk start MRI plus mammography at 30. NCCN aligns, calling for studies on dense breasts and supplemental MRI/CEM/US/AB-MRI.
When should high-risk women begin breast cancer screening?
ACS, NCCN, and SBI recommend high-risk women start annual mammography plus MRI at age 30, or earlier based on risk factors like family history. ACR suggests annual screening from age 25-30 for certain high-risk groups.
What role does breast density play in screening recommendations?
For dense breasts (BI-RADS C/D), ACP allows optional DBT supplements but rejects MRI/US/CEM. Critics and NCCN advocate supplemental screening like MRI, CEM, US, or AB-MRI to improve detection in dense tissue.
How is AI being incorporated into breast cancer screening?
Global experts recommend AI-based risk assessment from age 35 using mammograms. ACS suggests AI mammography starting at 35 for risk evaluation.
What are the SBI recommendations for screening?
SBI supports annual screening from age 40 for average-risk and earlier for higher-than-average risk, including those with benign surgery history. They criticize ACP and align with ACS/NCCN on high-risk protocols.
What advanced imaging techniques are mentioned for breast cancer screening?
Newer techniques include higher-resolution MRI, contrast-enhanced mammography, diffusion-weighted MRI, ultrafast DCE-MRI, deep learning models, and non-contrast high spectral MRI. Breast MRI is noted as highly sensitive for detection.
ACP new guidance: biennial mammo 50-74 average-risk, optional DBT supps dense C/D, rejects MRI/US/CEM—criticized by ACR/SBI/Spear as deadly; ACS/NCCN/SBI annual from 40 + risk at 25/35 (AI mammo from 35), MRI+mammo at 30 high-risk, supps MRI/CEM/US/AB-MRI; NCCN aligns, calls for dense studies.